Brain Ischemia in Alzheimer's Disease May Partly Counteract the Disruption of the Blood-Brain Barrier

被引:1
作者
Bateman, Grant A. [1 ,2 ]
Bateman, Alexander R. [3 ]
机构
[1] John Hunter Hosp, Dept Med Imaging, Newcastle, NSW 2310, Australia
[2] Newcastle Univ, Coll Hlth Med & Wellbeing, Sch Med & Publ Hlth, Callaghan Campus, Newcastle, NSW 2308, Australia
[3] Newcastle Univ, Coll Engn Sci & Environm, Sch Engn, Callaghan Campus, Newcastle, NSW 2308, Australia
关键词
Alzheimer's disease; blood-brain barrier; cerebral blood flow; CSF formation rate; glymphatic; ischemia; normal pressure hydrocephalus; NORMAL-PRESSURE HYDROCEPHALUS; MILD COGNITIVE IMPAIRMENT; VASCULAR DEMENTIA; CEREBRAL PERFUSION; VENOUS-PRESSURE; FLOW; PATHOGENESIS; METABOLISM; PHYSIOLOGY; HUMANS;
D O I
10.3390/brainsci15030269
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: In normal pressure hydrocephalus (NPH) there is blood-brain barrier (BBB) disruption, which should increase the CSF formation rate (CSFfr) and, therefore, also increase the intracranial pressure (ICP). However, the ICP is normal in NPH. A lumped parameter study was performed to look at the interrelation between the ICP, cerebral blood flow (CBF), and the degree of BBB disruption in NPH. The model suggested that the CSFfr could be reduced in this condition if the BBB disruption was moderated by a reduction in the capillary transmural pressure (TMP) secondary to arteriolar constriction and a reduced CBF. In early Alzheimer's disease (AD), there is BBB disruption, reduced ICP, and global ischemia. This raises the possibility that the same physiology may occur in AD as occurs in NPH. Methods: A lumped parameter model previously used to describe the hydrodynamics of NPH was modified to investigate the effects of changes in CSF pressure and blood flow in patients with mild cognitive impairment (MCI) and AD. Results: The model indicates that the average capillary TMP is normal in MCI, but decreases as AD progresses. Removing CSF in AD patients during a tap test initially increases the capillary TMP. The brain in AD responds to a tap test by increasing its level of ischemia, and this reduces the capillary TMP. Conclusions: A hypothesis is put forward that the BBB disruption in AD is partially mitigated by the brain making itself ischemic. Modelling gives support to this hypothesis. The model can suggest a cause for the development of ischemic neuronal loss and amyloid accumulation secondary to glymphatic flow disruption as AD progresses.
引用
收藏
页数:16
相关论文
共 50 条
[21]   Reconsidering the role of blood-brain barrier in Alzheimer's disease: From delivery to target [J].
Sousa, Joao Andre ;
Bernardes, Catarina ;
Bernardo-Castro, Sara ;
Lino, Miguel ;
Albino, Ines ;
Ferreira, Lino ;
Bras, Jose ;
Guerreiro, Rita ;
Tabuas-Pereira, Miguel ;
Baldeiras, Ines ;
Santana, Isabel ;
Sargento-Freitas, Joao .
FRONTIERS IN AGING NEUROSCIENCE, 2023, 15
[22]   Alzheimer's disease and drug delivery across the blood-brain barrier: approaches and challenges [J].
Iqbal, Iram ;
Saqib, Fatima ;
Mubarak, Zobia ;
Latif, Muhammad Farhaj ;
Wahid, Muqeet ;
Nasir, Bushra ;
Shahzad, Hamna ;
Sharifi-Rad, Javad ;
Mubarak, Mohammad S. .
EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2024, 29 (01) :313
[23]   Disruption of the blood-brain barrier in parkinson's disease: curse or route to a cure? [J].
Lee, Heyne ;
Pienaar, Ilse S. .
FRONTIERS IN BIOSCIENCE-LANDMARK, 2014, 19 :272-280
[24]   Role of ischmic blood-brain barrier on amyloid plaques development in Alzheimer's disease brain [J].
Pluta, Ryszard .
CURRENT NEUROVASCULAR RESEARCH, 2007, 4 (02) :121-129
[25]   The Impact of Docosahexaenoic Acid on Alzheimer's Disease: Is There a Role of the Blood-Brain Barrier? [J].
Pan, Yijun ;
Khalil, Hanan ;
Nicolazzo, Joseph A. .
CURRENT CLINICAL PHARMACOLOGY, 2015, 10 (03) :222-241
[26]   Editorial: Imaging of the blood-brain barrier in Alzheimer's disease and related disorders [J].
Uchida, Yuto ;
Shao, Xingfeng ;
Montagne, Axel ;
Matsukawa, Noriyuki .
FRONTIERS IN AGING NEUROSCIENCE, 2023, 15
[27]   Blood-Brain Barrier Breakdown in Alzheimer's Disease: Mechanisms and Targeted Strategies [J].
Alkhalifa, Amer E. ;
Al-Ghraiybah, Nour F. ;
Odum, Julia ;
Shunnarah, John G. ;
Austin, Nataleigh ;
Kaddoumi, Amal .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (22)
[28]   Upregulation of ribosome complexes at the blood-brain barrier in Alzheimer's disease patients [J].
Suzuki, Masayoshi ;
Tezuka, Kenta ;
Handa, Takumi ;
Sato, Risa ;
Takeuchi, Hina ;
Takao, Masaki ;
Tano, Mitsutoshi ;
Uchida, Yasuo .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2022, 42 (11) :2134-2150
[29]   Commentary on "Alzheimer's disease drug development and the problem of the blood-brain barrier" [J].
Simpkins, James W. .
ALZHEIMERS & DEMENTIA, 2009, 5 (05) :433-434
[30]   The blood brain barrier in Alzheimer's disease [J].
Chakraborty, A. ;
de Wit, N. M. ;
van der Flier, W. M. ;
de Vries, H. E. .
VASCULAR PHARMACOLOGY, 2017, 89 :12-18